Revenue, last quarter
$24.5M
−19.1% vs same quarter last year
Net income
−$16.2M
−65.3% vs same quarter last year
EPS, diluted
−$0.39
−62.5% vs same quarter last year
Operating cash flow
$45.2M
+3909.3% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $134.5M | −$38.9 |
| FY24 | $139.9M | −$27.5 |
| FY23 | $89.1M | −$48.6 |
| FY22 | $49M | −$66.8 |
| FY21 | $22.6M | −$48.7M |
| FY20 | $14.7M | $27.6M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 76.6% | −35.8% | 0% |
| FY24 | 70.7% | −26.3% | 0% |
| FY23 | 60.4% | −56.2% | 0% |
| FY22 | 43.5% | −129.2% | 0% |
| FY21 | 20% | −233.6% | −215.5% |
| FY20 | 11.6% | −241.3% | 187.9% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$19.3M |
| FY24 | −$22.4M |
| FY23 | −$46.4M |
| FY22 | −$61.2M |
| FY21 | −$46.6M |
| FY20 | −$37.7M |
| FY19 | - |
- RxSight
- Healthcare median
Show the numbers
| Year | RxSight | Healthcare median |
|---|---|---|
| FY25 | 0% | −30.6% |
| FY24 | 0% | −47% |
| FY23 | 0% | −58% |
| FY22 | 0% | −80.4% |
| FY21 | −215.5% | −71.9% |
| FY20 | 187.9% | −62.2% |
| FY19 | - | −46.3% |